Navigation Links
Fenwal to Host Webinar on the Safety of 2-Unit Red Cell Collections From Young Donors
Date:6/23/2009

n Red Cross and provide a strong rationale for recruitment of young donors."

The study also found that regional blood centers using Fenwal's ALYX(R) automated collection system reported a lower rate of adverse reactions than centers using a competitive device. The authors describe this finding as hypothesis-generating given limitations of the study's design such as variations in regional blood-center reporting, and recommend further study.

"This study is unique in the size of the data set, which includes more than 4.5 million blood donations," said Hiroshi Uchida, chief technology officer for Fenwal, Inc. "The findings should give blood centers and donors confidence in the safety, effectiveness and value of automated blood collection, especially for young donors, as well as the exceptional performance of Fenwal's technology."

The authors of the study explain that two-unit red cell collections via automation offer several advantages, including better inventory management of needed blood types and more consistent and controlled component quality. Consequently, blood centers are increasingly recruiting donors for two-unit red cell collections and more procedures are being performed at high school and college blood drives.

About Fenwal

Fenwal Inc. is a global medical technology company focused on improving blood collection, separation, safety and availability for patient care. Fenwal became an independent company in 2007, but its roots go back to 1949 with the founding of Fenwal Laboratories. Fenwal developed the first flexible, disposable container for blood collection, eliminating complications associated with glass containers and allowing blood to be separated into therapeutic components. Today, the company's products and advanced collection and separation technologies are used throughout the world to help ensure a safe and available supply of lifesaving blood and blood produ
'/>"/>

SOURCE Fenwal Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. AABB and Fenwal Sponsor Third Annual Blood Collectors Week
2. Fenwal Signs Development, Distribution and Licensing Agreement With Data Innovations, Inc.
3. Fenwal Names 2008 Inductees for Blood Donation Hall of Fame
4. Fenwal Statement Regarding Patent Litigation
5. Uncover Key Competitive Intelligence Insights in Webinars Hosted by Best Practices
6. Portico Systems Offers Webinar Series to Share Provider Network Management Best Practices
7. FairWarning to Host Webinar Featuring HIMSS Chairman and Healthcare Executive from PricewaterhouseCoopers on Electronic Health Record Privacy and Compliance Challenges
8. Pharsight to Host Webinar on Hepatitis C Virus (HCV) and HIV Drug-Disease Modeling
9. Achieving CVIS Goals Webinar
10. Agilysys Hosts IBM Specialist at Health Care Webinar Offering Data Storage Solutions
11. Plexus Systems, Inc. and Aberdeen Group Co-host March 27 Webinar on Manufacturing Efficiency
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... Glaser Pediatric AIDS Foundation (EGPAF) and the American Cancer ... to essential pain medications for people living with HIV ... Pain initiative, this new partnership will help improve efforts ... the country. , Swaziland has the highest HIV ... of adults ages 15-49 infected. Many of these individuals ...
(Date:7/29/2014)... 2014 Regents Health Resources, a consulting ... brought health care industry veteran Daryl Demonbreun and former ... lead the company’s ambitious plans to grow into a ... been moving along at a steady pace for nearly ... a notch,” says Bob Maier, founder and chief executive ...
(Date:7/29/2014)... Test instruments after processing to assure ... where it matters most – on the surgical ... premium domestic appliances, introduces ProCare Protein Check, a ... cleaned. The ProCare liquid is applied directly to ... After 3 minutes, users visually determine the presence ...
(Date:7/29/2014)... that death rates rise in association with extremely hot ... summer of 2003, for example, resulted in about 22,000 ... Alex-andra Schneider at the Institute of Epidemiology II at ... temperatures on the number of deaths caused by cardiovascular ... and low temperatures in the study. , "Our findings ...
(Date:7/29/2014)... July 29, 2014 Healthcare staffing ... 2014 Nurses of Tomorrow Scholarship Competition winners:, ... Reno, NV ,     Racheal D., Freshman, Cerritos ... Junior, Houston Community College in Houston, TX ... Week, Medical Solutions hosts the Nurses of Tomorrow ...
Breaking Medicine News(10 mins):Health News:New partnership to improve access to essential pain medications for people living with HIV 2Health News:Sferrella and Demonbruen Join Regents Health Resources 2Health News:ProCare Protein Check Tests Surgical Instruments to Verify Effective Cleaning 2Health News:Mortality rates increase due to extreme heat and cold 2Health News:Medical Solutions Announces Nurses of Tomorrow Scholarship Winners 2
... veterinarians with a new way to understanding and treating heartworm in ... ... -- Merial today announced the availability of an educational CD for ... of heartworm prevention and treatment in dogs. Launched at the North ...
... As the unemployment rate grows, so do,the numbers ... with the,loss of health insurance. COBRA continuation coverage can ... workers have the right to,purchase such coverage, only about ... high. A November 2008 study by non-profit advocacy group,Families ...
... companies pull products from shelves as FDA advises consumers ... while salmonella probe continues , , MONDAY, Jan. 19 (HealthDay ... peanut butter products continued without letup Monday, as more ... store shelves. , The actions followed a U.S. Food ...
... Jan. 19 The 66th Annual Golden Globe Awards ... smiles this year thanks to the Kari Feinstein,s 2009 ... of the style lounge included Paris Hilton, Jessica Alba ... Kellan Lutz (Emmett Cullen). Proceeds of the lounge supported ...
... Health Innovation Discusses the Impact of the Economic Crisis on ... A new report released today from the ... to health providers, has found that hospitals and health systems ... spending and unprofitable healthcare services as a result of the ...
... Jan. 19 Abbott announced today,that the ... status,under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) ... blood analyzer. , Cartridges for ... a patient,s,metabolic state within a few minutes. The ...
Cached Medicine News:Health News:Heartworm CD by Merial Offers Unique Approach to Managing this Deadly Condition 2Health News:Heartworm CD by Merial Offers Unique Approach to Managing this Deadly Condition 3Health News:Is Your Business Ready for the COBRA Premium Subsidy? 2Health News:Peanut Butter Product Recalls Mount 2Health News:Peanut Butter Product Recalls Mount 3Health News:Photos: Opalescence Treswhite Supreme Adds Glimmer to 'Twilight' Film Actor's Smile 2Health News:Hospitals and Health Systems to Cut Back on Both Capital Spending and Unprofitable Services in 2009 2Health News:Hospitals and Health Systems to Cut Back on Both Capital Spending and Unprofitable Services in 2009 3Health News:Hospitals and Health Systems to Cut Back on Both Capital Spending and Unprofitable Services in 2009 4Health News:Abbott Receives FDA CLIA Waiver for Use of Five Additional Cartridges on the i-STAT Handheld Blood Analyzer 2Health News:Abbott Receives FDA CLIA Waiver for Use of Five Additional Cartridges on the i-STAT Handheld Blood Analyzer 3
(Date:7/29/2014)... and TORONTO ... Acquisitions Corporation (OTCBB: ESAQ), an emerging pharmaceutical ... development of improved novel formulations and alternative ... announces expansion of its pharmaceutical development implementing ... direction includes large molecule drugs that will address ...
(Date:7/29/2014)... , July 29, 2014  Based on ... systems (PERS) market, Frost & Sullivan recognizes MobileHelp ... Award for Price Performance Value Leadership. MobileHelp,s leadership ... captures expectations for tech progression in personal emergency ... for these solutions. MobileHelp is at ...
(Date:7/29/2014)... Medical Corporation (Apex, TWSE: 4106), a leading player in the ... is appealing the judgment of the Regional Court of ... that found the headgear of certain mask models infringe a ... against various ResMed patents in major countries. Apex further reiterates ... ResMed filed the lawsuit with the Regional ...
Breaking Medicine Technology:EastGate Acquisitions Announces Expansion of its Pharmaceutical Developments Implementing its Sub-Micron Platform Technology 2EastGate Acquisitions Announces Expansion of its Pharmaceutical Developments Implementing its Sub-Micron Platform Technology 3EastGate Acquisitions Announces Expansion of its Pharmaceutical Developments Implementing its Sub-Micron Platform Technology 4Frost & Sullivan Applauds MobileHelp for its Targeted Supplies for the PERS Market 2Frost & Sullivan Applauds MobileHelp for its Targeted Supplies for the PERS Market 3Apex Continues Fighting Against Patents to Free Up Competition 2
... 2011 Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... and commercialization of products for central nervous system disorders, ... one of Israel,s leading private biotech, pharmaceutical and medical ... Israel. "We are excited to reach this ...
... Cell Therapeutics, Inc. ("CTI") (NASDAQ: CTIC ... that final results from the phase II OPAL study ... acute myeloid leukemia (AML) were presented by Jorge Cortes, ... Center during the Acute Myeloid Leukemia - Therapy, excluding ...
Cached Medicine Technology:Vanda Pharmaceuticals Enters into an Exclusive License Agreement with Megapharm Ltd. for Commercialization of Fanapt™ in Israel 2Vanda Pharmaceuticals Enters into an Exclusive License Agreement with Megapharm Ltd. for Commercialization of Fanapt™ in Israel 3Vanda Pharmaceuticals Enters into an Exclusive License Agreement with Megapharm Ltd. for Commercialization of Fanapt™ in Israel 4Final OPAL Phase II Results of Tosedostat Demonstrate Significant Response Rates in Elderly Patients with Treatment Refractory or Relapsed Primary or Secondary Acute Myeloid Leukemia (AML) 2Final OPAL Phase II Results of Tosedostat Demonstrate Significant Response Rates in Elderly Patients with Treatment Refractory or Relapsed Primary or Secondary Acute Myeloid Leukemia (AML) 3Final OPAL Phase II Results of Tosedostat Demonstrate Significant Response Rates in Elderly Patients with Treatment Refractory or Relapsed Primary or Secondary Acute Myeloid Leukemia (AML) 4
... and removal in the urinary tract. The nitinol ... shape following extreme torsion. The unique tipless design ... basket to open at the base of the ... reduces the likelihood of mucosal damage and perforation. ...
... Used for soft-tissue ... limited to paravaginal repairs, ... or rectocele. Surgisis® ES ... enhanced strength for intraoperative ...
... Used for temporary suprapubic urinary diversion ... puncture the bladder. The access sheath is ... Once the catheter is introduced, the access ... low-profile catheter support is included for external ...
... and a FAM-labeled probe targeting the VP1 gene ... ASR contains primers and a Texas Red-labeled probe ... an instrument that can detect FAM and Texas ... Analyte Specific Reagent* (ASR) program is comprised of ...
Medicine Products: